GFAP and Cognitive impairment: Although the relationship between plasma GFAP levels and clinical scores in PD patients remains incompletely understood, recent studies have demonstrated higher plasma GFAP levels in PD patients with dementia and mild cognitive impairment than in controls [14, 31].